394 related articles for article (PubMed ID: 19106146)
21. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo M; Wu JC; Park EE; Tanzella F
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):650-4. PubMed ID: 16785411
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors for central compartment lymph node metastasis in thyroid papillary microcarcinoma.
Lee SH; Lee SS; Jin SM; Kim JH; Rho YS
Laryngoscope; 2008 Apr; 118(4):659-62. PubMed ID: 18176339
[TBL] [Abstract][Full Text] [Related]
23. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
24. [Microscopic thyroid papillary cancers presenting as cervical lymph node metastases].
Emy P; Michenet P; Saint-Marc O
Ann Chir; 1998; 52(5):461-4. PubMed ID: 9752488
[TBL] [Abstract][Full Text] [Related]
25. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
[TBL] [Abstract][Full Text] [Related]
27. Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age.
Miccoli P; Minuto MN; Ugolini C; Panicucci E; Massi M; Berti P; Basolo F
Otolaryngol Head Neck Surg; 2008 Feb; 138(2):200-3. PubMed ID: 18241716
[TBL] [Abstract][Full Text] [Related]
28. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
29. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
[TBL] [Abstract][Full Text] [Related]
30. [Management of lymph node metastases in well-differentiated and medullary thyroid cancer: retrospective study on 52 cases].
Antonelli AR; Piazza C; Lombardi D; Casigli F
Ann Ital Chir; 2004; 75(3):305-14. PubMed ID: 15605518
[TBL] [Abstract][Full Text] [Related]
31. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.
Grodski S; Cornford L; Sywak M; Sidhu S; Delbridge L
ANZ J Surg; 2007 Apr; 77(4):203-8. PubMed ID: 17388820
[TBL] [Abstract][Full Text] [Related]
32. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
[TBL] [Abstract][Full Text] [Related]
33. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
[TBL] [Abstract][Full Text] [Related]
35. Lymph node dissection in papillary or follicular thyroid carcinoma.
Bononi M; Tocchi A; Cangemi V; Vecchione A; Giovagnoli MR; De Cesare A; Fiori E; Volpino P; Brozzetti S; Meucci M; Scozzafava S; Cavallaro A
Anticancer Res; 2004; 24(4):2439-42. PubMed ID: 15330196
[TBL] [Abstract][Full Text] [Related]
36. [The characteristics of papillary thyroid cancer lymph node metastasis and the clinical significance of central region cervical lymph node dissection].
Li Z; Qu XC; Cheng B
Zhonghua Wai Ke Za Zhi; 2008 Sep; 46(18):1407-9. PubMed ID: 19094514
[TBL] [Abstract][Full Text] [Related]
37. [Lymph node dissection in non-medullary differentiated thyroid carcinoma].
Mathonnet M
Ann Chir; 2006; 131(6-7):361-8. PubMed ID: 16329987
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
40. Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases.
Chen H; Udelsman R
Surg Oncol Clin N Am; 1998 Oct; 7(4):645-63. PubMed ID: 9735127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
